 ENGLEWOOD, CO ACCESSWIRE January 24, 2023 Aytu BioPharma, Inc. the Company or Aytu NASDAQ:AYTU, a commercial stage pharmaceutical and consumer health company providing pediatric-focused prescription drugs and cost-effective consumer health solutions, today announced that Josh Disbrow, Chief Executive Officer, will present and host one-on-one meetings with investors at the Lytham Partners Investor Select Conference, taking place virtually on January 31, 2023. Company Webcast The Companys webcast presentation will be available for viewing at 9:00 am ET on Tuesday, January 31, 2023, on the Companys website at or at 